Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
40.93
+0.12 (+0.29%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,083,763
Open
41.26
Bid (Size)
40.90 (100)
Ask (Size)
40.96 (800)
Prev. Close
40.81
Today's Range
40.23 - 41.41
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
2.85%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
↗
Today 14:20 EDT
There are other factors to consider before investing in this -- or any other -- healthcare company.
Via
The Motley Fool
Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market
↗
Today 4:28 EDT
Lilly's revenue has soared thanks to its obesity drugs.
Via
The Motley Fool
Performance
YTD
-21.9%
-21.9%
1 Month
+6.5%
+6.5%
3 Month
-28.3%
-28.3%
6 Month
-27.0%
-27.0%
1 Year
-34.9%
-34.9%
More News
Read More
The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust
↗
April 15, 2026
Via
The Motley Fool
Could AbbVie Crash Lilly's Weight‑Loss Party?
↗
April 14, 2026
Via
The Motley Fool
The Global Pantry Reimagined: Unilever and McCormick Seal $65 Billion Merger Deal
April 09, 2026
Via
MarketMinute
Topics
Economy
Supply Chain
The "Daily Pill" Revolution: Eli Lilly’s Orforglipron Shatters Records with 25% Weight Loss
April 08, 2026
Via
MarketMinute
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
↗
April 08, 2026
Via
The Motley Fool
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
↗
April 08, 2026
Via
The Motley Fool
Topics
Economy
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Goldman Sachs Forecasts 12% S&P 500 Surge in 2026: The Five Pillars of a Maturing Bull Market
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Nuclear, Pharma & Travel Buybacks: Confident or Cautious Signals?
↗
April 06, 2026
Via
MarketBeat
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
↗
April 04, 2026
Via
The Motley Fool
Earnings Revision Momentum: Why Analysts Upgraded S&P 500 Growth to 17%
April 03, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market
↗
April 03, 2026
Via
The Motley Fool
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via
MarketMinute
Topics
Economy
The Evolution of The Cigna Group: A Deep Dive into a Health Services Powerhouse (2026)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Lawsuit
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Eli Lilly Stock Trounced the Market Today
↗
April 01, 2026
Via
The Motley Fool
Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance
April 01, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Could This New Approval Be a Turning Point For Novo Nordisk?
↗
April 01, 2026
Via
The Motley Fool
Is This Weight Loss Drug Stock a Buy After a New Approval?
↗
March 31, 2026
Via
The Motley Fool
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via
Finterra
Topics
Economy
Intellectual Property
1 Reason This Biotech Stock Could Triple Before Year-End
↗
March 29, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 40.93
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/16/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.